Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$238.08 - $288.0 $4.45 Million - $5.39 Million
-18,702 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$250.72 - $291.24 $3.12 Million - $3.63 Million
12,447 Added 198.99%
18,702 $4.96 Million
Q2 2021

Aug 16, 2021

BUY
$235.0 - $310.7 $1.47 Million - $1.94 Million
6,255 New
6,255 $1.73 Million
Q3 2018

Nov 14, 2018

SELL
$121.55 - $156.8 $2.02 Million - $2.6 Million
-16,602 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$112.2 - $165.95 $1.86 Million - $2.76 Million
16,602 New
16,602 $1.5 Million
Q1 2018

May 15, 2018

SELL
$84.6 - $126.1 $1.4 Million - $2.09 Million
-16,602 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$91.55 - $115.85 $1.52 Million - $1.92 Million
16,602
16,602 $1.5 Million

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.09B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.